Clinical Trials
19 trialsNCT00930332 2024-02-12
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
Canadian Cancer Trials Group
Phase 1 Terminated
NCT04478630 2023-09-18
CINV
Milton S. Hershey Medical Center
Phase NA Terminated
NCT00285051 2020-12-23
Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy
Rafa Laboratories
Phase 2 Terminated
NCT00394602 2020-01-02
Chemoradiation-Induced Nausea and Emesis: Quality of Life
M.D. Anderson Cancer Center
Terminated
NCT00206440 2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3 Terminated
NCT01874119 2018-06-07
HDIL2/Emend
St. Louis University
Phase 2 Terminated
NCT01275664 2018-05-22
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
GOG Foundation
Phase NA Terminated
NCT00903396 2017-11-24
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Terminated
NCT00334646 2017-11-17
Cyclophosphamide Drug Interaction Study In Cancer Patients
GlaxoSmithKline
Phase 1 Terminated
NCT01649258 2017-11-17
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
University of Southern California
Phase 1 Terminated
NCT00895245 2017-05-18
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
University of Washington
Phase 2 Terminated
NCT00900068 2017-05-09
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
OHSU Knight Cancer Institute
Terminated
NCT01031953 2017-05-09
Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
OHSU Knight Cancer Institute
Phase 1/2 Terminated
NCT02550119 2017-03-28
Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy
University of Southern California
Phase NA Terminated
NCT01996410 2016-11-21
The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients
OhioHealth
Phase NA Terminated
NCT01135550 2016-05-05
Low Dose Versus Usual Dose Dexamethasone for Symptom Control in Children Undergoing Cranial or Craniospinal Radiation
The Hospital for Sick Children
Phase 3 Terminated
NCT01132547 2015-07-02
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
University of South Florida
Phase 3 Terminated
NCT00429702 2014-07-25
Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy
University of South Florida
Phase 2 Terminated
NCT00869973 2013-01-23
Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients
S. Maria Hospital, Terni
Phase 3 Terminated